ISPAT did not step off the gas as 2017 drew to an end. The team undertook a very comprehensive agenda in November and December as their investment attraction and promotion activities picked up speed. A main country of interest this past month for ISPAT President Arda Ermut and his delegation was Switzerland, where they held a number of meetings with the top management of major Swiss companies in various parts of the country.
The series of meetings saw the ISPAT delegation visit globally renowned elevator company Schindler Group’s Executive Committee Member Carlos Guembe at the company’s head office in Ebikon. The visit also saw Ermut present Türkiye’s value proposition to Swiss technology and engineering companies at a roundtable held at the Switzerland Global Enterprise (S-GE) headquarters in Zurich.
Later on, ISPAT discussed collaboration on R&D opportunities with Christof Domeisen, CEO at Swiss Angst+Pfister Group, which supplies products and engineering to top-tier OEMs from its Turkish plant.
ISPAT's Switzerland program also included executive meetings in Pratteln with the Clairant Group, which is one of the world's leading specialty chemical companies and has been operational in Türkiye with various manufacturing facilities since 1992. Lastly, the ISPAT delegation met with Novartis Chairman Joerg Reinhardt at the company’s Basel head office. Pharma giant Novartis exports to 100 countries from its four Turkish plants, currently occupying the number one position in Türkiye’s pharma exports.